Centene Corporation CNC
Set alert
68.45 USD -0.17 -0.25%
At close · Oct 30
68.89 +0.44 +0.64%
After hours · Oct 30, 8:00 PM ET
66.82 Day range 70.17
31.80 52-week range 71.24
- YTD
- +66.34%
- 1 year
- +95.46%
- Open
- 69.31
- Prev close
- 68.62
- Mkt cap
- 33.89B
- Vol
- 4.81M
- Avg vol
- 4.51M
- EPS
- 2.91
- P/E
- 23.52
- Div yield
- 0.00%
More statistics
- Low
- 66.82
- High
- 70.17
- Forward P/E
- 12.51
- Beta
- 1.13
- Short ratio
- 2.30
- Inst. own
- 101.79%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 5, 2027
- 50-d avg
- 66.02
- 200-d avg
- 55.24
- 1y target
- 74.50
5Y chart
Events in this range
- Oct 29, 2025Earnings: 0.5; estimate -0.14475; surprise 445.42%
- Feb 6, 2026Earnings: -1.19; estimate -1.22007; surprise 2.46%
- Apr 28, 2026Earnings: 3.37; estimate 2.23; surprise 51.12%
- Jul 28, 2026Earnings: 2.51; estimate 1.09; surprise 130.28%
- Oct 27, 2026Earnings: 0.58; estimate 0.0957; surprise 506.06%
- Oct 28, 2026Rating: Baird · Neutral → Neutral
- Oct 28, 2026Rating: Barclays · Overweight → Overweight
- Oct 28, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 28, 2026Rating: UBS · Neutral → Neutral
- Oct 29, 2026Rating: JP Morgan · Neutral → Neutral
- Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (96)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| RSI: Oversold | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| SMA: Bearish | May 20, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 22, 2024 | 2 years ago |
| SMA: Bullish | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 11, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 4, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bearish | Jun 12, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| SMA: Bullish | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 24, 2023 | 3 years ago |
| SMA: Bearish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 10, 2023 | 3 years ago |
| RSI: Oversold | Mar 27, 2023 | 3 years ago |
| RSI: Oversold | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Jan 31, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
| SMA: Bullish | Jan 10, 2022 | 4 years ago |
Key statistics
- Market cap
- 33.90B
- Enterprise value
- 26.03B
- Trailing P/E
- 23.53
- Forward P/E
- 12.51
- PEG ratio
- 0.83
- Price / sales
- 0.19
- Price / book
- 1.53
- EPS (TTM)
- 2.91
- Beta
- 1.13
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.81%
- Revenue (TTM)
- 180.41B
- Revenue growth
- 0.20%
- Free cash flow
- 3.08B
- Total cash
- 23.59B
- Total debt
- 15.54B
- Return on equity
- 6.74%
- Shares outstanding
- 495.07M
- Short % of float
- 2.53%
- 50-day average
- 66.02
- 200-day average
- 55.24
Analyst view
Consensus: buy
Buy
Price target (mean) 74.50 +8.8% upside
Now 68.45
- Target (low)
- 56.00
- Target (mean)
- 74.50
- Target (high)
- 85.00
Ratings (0m) 21 8 buy · 12 hold · 1 sell
- Strong buy1
- Buy7
- Hold12
- Sell1
- Strong sell0
Next earnings
Feb 5, 2027
Expected Feb 5, 2027. Consensus EPS estimate -1.12.
Financials — quick view
CNC Revenue — quarterly 50.65B
CNC Net income — quarterly -71.00M
CNC EPS — quarterly -0.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 5, 2027 | Dec 30, 2026 | -1.15 | — | — | — |
| Oct 27, 2026 | Sep 30, 2026 | 0.0957 | 0.58 | +0.48 | +506.06% |
| Jul 28, 2026 | Jun 30, 2026 | 1.09 | 2.51 | +1.42 | +130.28% |
| Apr 28, 2026 | Mar 31, 2026 | 2.23 | 3.37 | +1.14 | +51.12% |
| Feb 6, 2026 | Dec 31, 2025 | -1.22 | -1.19 | +0.03 | +2.46% |
| Oct 29, 2025 | Sep 30, 2025 | -0.14475 | 0.50 | +0.64 | +445.42% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 28, 2026 | UBS | main | Neutral | Neutral |
| Oct 28, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Oct 28, 2026 | Barclays | main | Overweight | Overweight |
| Oct 28, 2026 | Baird | main | Neutral | Neutral |
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- centene.com
News
- Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $75
- JP Morgan Maintains Neutral on Centene, Raises Price Target to $75
- Morgan Stanley Maintains Equal-Weight on Centene, Raises Price Target to $71
- Are You Looking for a Top Momentum Pick? Why Centene (CNC) is a Great Choice
- Barclays Maintains Overweight on Centene, Raises Price Target to $82
- Why Centene (CNC) is a Top Value Stock for the Long-Term
- Should Value Investors Buy Centene (CNC) Stock?
- Coca-Cola To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday
- Centene Analysts Boost Their Forecasts Following Upbeat Q3 Earnings
- Centene Analysts Boost Their Forecasts Following Upbeat Q3 Earnings
Your note
Sign in to keep a note on CNC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ASHER ANDREW LYNN | Chief Financial Officer | Stock Award(Grant) | Jan 25, 2026 | 831,216 |
| BURDICK KENNETH A | Director | Sale | Jun 9, 2026 | 283,584 |
| CASSO KATIE | Officer | Stock Award(Grant) | Jan 25, 2026 | 122,371 |
| DALLAS HIRAM JAMES | Director | Stock Award(Grant) | May 11, 2026 | 49,567 |
| EPPINGER FREDERICK H | Director | Stock Award(Grant) | Sep 29, 2026 | 370,402 |
| KOSTER CHRISTOPHER A. | General Counsel | Sale | Aug 25, 2026 | 248,954 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.37% | 41,446,046 | 2.84B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.36% | 31,478,140 | 2.16B | Jun 29, 2026 |
| AQR Capital Management, LLC | 5.79% | 28,678,701 | 1.96B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.52% | 22,352,704 | 1.53B | Jun 29, 2026 |
| State Street Corporation | 4.44% | 21,965,370 | 1.50B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.69% | 13,309,729 | 911.32M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 15,674,974 | 1.07B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.46% | 12,157,702 | 832.44M | Jun 29, 2026 |
| HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Select Fund | 1.52% | 7,525,000 | 515.24M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 6,582,063 | 450.67M | Sep 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.24% | 6,149,030 | 421.02M | Jul 30, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.23% | 6,089,434 | 416.94M | Aug 30, 2026 |